Observational Study
Copyright ©The Author(s) 2023.
World J Clin Cases. May 26, 2023; 11(15): 3491-3501
Published online May 26, 2023. doi: 10.12998/wjcc.v11.i15.3491
Table 1 Basic data of enrolled patients (n, %, mean ± SD)
GroupsGender (male)Gender (female)Age (yr)BMIPre-operation ABICourse of disease (h)
Enrolled patients (n = 62)38 (61%)24 (39%)55-83 (69.52 ± 7.45)18.10-24.62 (21.87 ± 1.91)0.21-0.46 (0.33 ± 0.06)2.67-64.17 (13.22 ± 10.85)
Table 2 Comparison of age, pre-operation, body mass index and course of disease between the two groups (n, mean ± SD)
Groups
Age (yr)
Pre-operation ABI
BMI
Course of disease (h)
Control group (n = 34)57-81 (69.94 ± 7.66)0.21-0.46 (0.34 ± 0.06)18.10-24.59 (21.79 ± 1.97)2.70-63.93 (13.25 ± 10.87)
Observation group (n = 28)55-83 (69.00 ± 7.29)0.21-0.46 (0.33 ± 0.05)18.19-24.62 (21.97 ± 1.88)2.65-64.12 (13.21 ± 10.84)
t value0.0590.5380.3810.015
P value0.9560.5920.7050.989
Table 3 Comparison of gender difference between the two groups, n (%)
Groups
Control group (n = 34)
Observation group (n = 28)
χ2 value
P value
Gender (male)21 (62)17 (61)0.0070.932
Gender (female)13 (38)11 (39)
Table 4 Comparison of efficacy between the two groups, n (%)
Groups
Recovery
Good
Fair
Poor
Amputa-tion/death
Total effective rate
Control group (n = 34)18 (52.94)10 (29.41)5 (14.71)1 (2.94)0 (0)33 (97.06)
Observation group (n = 28)16 (57.14)8 (28.57)4 (14.29)0 (0.00)0 (0)28 (100.00)
χ2 value0.837
P value0.360
Table 5 Comparison of surgical indicators between the two groups (n, mean ± SD)
Group
Pain score (point)
ABI difference before and after operation
Operation time (h)
Time to get out of bed (h)
Hospital stay (d)
Control group (n = 34)3.97 ± 0.940.59 ± 0.133.51 ± 0.4525.18 ± 1.778.04 ± 0.75
Observation group (n = 28)1.71 ± 0.710.56 ± 0.112.53 ± 0.3216.32 ± 2.485.80 ± 0.98
t value10.4800.7399.57916.39010.150
P value0.0000.4630.0000.0000.000
Table 6 Comparison of postoperative complication rates and recurrence rates between the two groups, n (%)
Groups
Ischemia reperfusion injury syndrome (case)
Infection of puncture site/incise-on (case)
Bleeding at puncture site/incise-on (case)
Puncture site/incise-on hematoma (case)
Lymphatic leakage (case)
Recurrence (case)
Distal embolism (case)
Hemoglob-inuria (cases)
Patients with complications (cases)
Control group (n = 34)23 (0.68)2 (0.06)4 (0.12)3 (0.09)3 (0.09)4 (0.12)2 (0.06)0 (0)24 (0.71)
Observation group (n = 28)10 (0.36)0 (0)0 (0)0 (0)0 (0)3 (0.11)4 (0.14)3 (0.11)10 (0.36)
χ2 value6.2891.7023.5212.5962.5960.0171.2403.8287.540
P value0.0120.1920.0610.1070.1070.8970.2650.0500.006
Table 7 Comparison of deaths between the two groups, n (%)
Group
Death
Control group (n = 34)1 (2.90)
Observation group (n = 28)1 (3.60)
χ2 value0.020
P value0.889
Table 8 Comparison of survival between two groups (n, mean ± SD)
Group
Survival time (wk)
Control group (n = 34)77.32 ± 2.06
Observation group (n = 28)76.57 ± 2.06
t value1.432
P value0.158